Shares of Vital Therapies (NYSE:VTL) have received a consensus recommendation of “Hold” from the seven ratings firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The average twelve-month […]